ConCallIQ
Go Pro

Bajajfinsv FY24 Annual Earnings Summary

4 quarters covered · ₹1,10,382 Cr revenue · ₹15,595 Cr PAT · 37.0% average EBITDA margin.

Total annual revenue: ₹1,10,382 Cr
Annual PAT: ₹15,595 Cr
Average margin: 37.0%
Promise delivery: 0%

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q1 FY24₹23,280 Cr₹3,709 Cr40.0%bullish
Q2 FY24₹26,023 Cr₹3,756 Cr38.0%bullish
Q3 FY24₹29,038 Cr₹4,045 Cr36.0%bullish
Q4 FY24₹32,041 Cr₹4,085 Cr34.0%bullish

Management promises made during the year

BALIC to maintain NBV growth in line with past trends

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY24
missed
BALIC product mix to normalize from Q2

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY24
missed
BAGIC combined ratio to be slightly above 100% for next few quarters

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY24
missed
BALIC NBV growth expected to continue with product mix improvement

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY24
missed
BFL to maintain long-term financial guidance metrics

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY24
missed
Bajaj Allianz Life to maintain market-leading growth

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY24
missed
Bajaj Allianz General to sustain above-industry growth

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY24
missed
Bajaj Finance to resume digital card issuance soon

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY24
missed

Risks flagged during the year

Q4 FY24 · high

No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.

Q1 FY24 · medium

Private players are aggressively bidding for crop insurance to utilize EoM allowances, potentially compressing margins for BAGIC.

Q1 FY24 · medium

Heavy rainfall in North India may lead to elevated motor and property claims, though management expects material impact to be assessed only in Q2 call.

Q1 FY24 · medium

Retail health loss ratios remain elevated due to fraud and claims inflation; management is investing in analytics but improvement may take time.

Q2 FY24 · medium

The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.

Q2 FY24 · medium

BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.

Q2 FY24 · medium

Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.

Q2 FY24 · medium

Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.

Q3 FY24 · medium

Proposed IRDAI changes to surrender values could impact product profitability and persistency.

Q3 FY24 · medium

Motor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.

Q3 FY24 · medium

Banks may prioritize deposits over third-party products, pressuring bancassurance growth.

Q4 FY24 · medium

Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.

What changed through the year

G

Q1 FY24 · BALIC to maintain NBV growth in line with past trends

Management expects absolute NBV to grow at a similar pace as historical 24% rolling 12-month growth, with margins stabilizing around 15%.

G

Q1 FY24 · BAGIC to sustain motor growth for 1-2 years

Expansion in distribution and geographies is expected to sustain motor growth in the medium term, though market dynamics may affect it.

G

Q1 FY24 · BALIC product mix to normalize from Q2

After a tactical Q1 with higher ULIP share, PAR mix is expected to revert to December 2022 levels, with corrective actions already taken in July.

G

Q2 FY24 · BAGIC combined ratio to be slightly above 100% for next few quarters

Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.

G

Q2 FY24 · BALIC NBV growth expected to continue with product mix improvement

Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.

G

Q2 FY24 · BFL to maintain long-term financial guidance metrics

BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.

G

Q3 FY24 · Bajaj Allianz Life to maintain market-leading growth

Management expects continued strong growth in IRNB, with focus on product mix and channel diversification.

G

Q3 FY24 · Bajaj Allianz General to sustain above-industry growth

The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion.

G

Q3 FY24 · Bajaj Finserv Health to scale via Vidal acquisition

The acquisition of Vidal Healthcare will accelerate Finserv Health's position in the healthcare payment spectrum.

G

Q3 FY24 · Bajaj Finance to resume digital card issuance soon

Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.

G

Q4 FY24 · BAGIC to maintain above-market growth with balanced profitability

Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given.

G

Q4 FY24 · BALIC to grow faster than industry with improving margins

Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided.

G

Q4 FY24 · Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25

Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.